Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LTB4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL32P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZGLP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR5047 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6859-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFT27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXJ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on